Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Novus Biologicals™ Imiquimod, TLR7 ligand
SDP

Applications: Functional, In vitro assay, Ligand Activation

Supplier:  Novus Biologicals™ NBP2262280.125MG

Catalog No. NBP22622801


Explore available promotions
Add to Cart

Description

Description

Imiquimod, TLR7 ligand is an imidazoquinoline amine analog to guanosine. As a synthetic molecule of the Imidazoquinoline family, it has potent immunostimulatory activity. Imiquimod has been shown to activate only TLR7. This activation is MyD88 dependant and leads to the induction of the transcription factor NF-kB. Buffer: 125μg in 50μL of DMSO (formerly supplied in sterile water) Endotoxin Note: <0.001 EU/μg MW: 276.8
Specifications

Specifications

2.5 mg/mL
Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.
This product is useful for activation of TLR7 and stimulation of TLR7 has been achieved with 5 to 10μL. Use in ligand activation, functional, and in vitro reported in scientific literature (PMID 25957979)
Human/Mouse
C14H16N4, HCl
0.125 mg
Imiquimod, TLR7 ligand
Product Suggestions

Product Suggestions

SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Provide Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.